Anlotinib or platinum-pemetrexed as second-line therapy in EGFR T790M-negative lung cancer - Zhong, Run-Bo; Xu, Jian-Lin; Lou, Yu-Qing; Chu, Tian-Qing; Zhong, Hua; Han, Bao-Hui (Annals of Palliative Medicine, 2020)